A concomitant therapy of GLP-1 receptor agonist (GLP-1 RA) along with conventional hypoglycemia treatment is also shown to improve cardiac function along with reduction in systematic inflammation and circulating BNP levels in cardiac resynchronization therapy with a defibrillator in failing heart patients [57]. The gene discussed is NPPB; the disease is Hypoglycemia.